SCHEMBL25096348

SCHEMBL25096348

Cc1cn2cc(NC(=O)c3ccc(N4CCNCC4)c4nccnc34)cc(F)c2n1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FGFR3 P22607 1/20 0.39
▸ PTK6 Q13882 1/20 0.38
▸ AURKB Q96GD4 1/20 0.38
▸ MAPKAPK2 P49137 1/20 0.38
▸ CSF1R P07333 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ USP28 Q96RU2 6/20 0.36
▸ USP25 Q9UHP3 5/20 0.36
▸ HDAC3 O15379 2/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ HDAC1 Q13547 1/20 0.35
▸ CCNT1 O60563 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CCND1 P24385 1/20 0.35
▸ CCND3 P30281 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ CDK6 Q00534 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31082627 0.97 FGFR3 (0.39) FGFR3PTK6AURKBMAPKAPK2CSF1R
SCHEMBL25096793 0.93 USP28 (0.41) FGFR3PTK6AURKBMAPKAPK2ALDH1A1
SCHEMBL30217695 0.92 USP28 (0.41) FGFR3PTK6AURKBMAPKAPK2ALDH1A1
SCHEMBL25096319 0.92 USP28 (0.41) FGFR3PTK6AURKBMAPKAPK2ALDH1A1
SCHEMBL25096717 0.92 PRNP (0.42) FGFR3ALDH1A1
SCHEMBL30217746 0.91 MAPKAPK2 (0.38) PTK6AURKBMAPKAPK2ALDH1A1USP28
SCHEMBL29256953 0.91 MAPKAPK2 (0.38) PTK6AURKBMAPKAPK2ALDH1A1USP28
SCHEMBL25096532 0.91 MAPKAPK2 (0.35) PTK6AURKBMAPKAPK2ALDH1A1USP28
SCHEMBL25095816 0.91 CSF1R (0.40) FGFR3PTK6AURKBCSF1RALDH1A1
SCHEMBL30217728 0.91 CSF1R (0.40) FGFR3PTK6AURKBCSF1RALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023034811-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2023-03-09 — — WO disclosed
EP-4110464-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2023-01-04 — — EP disclosed
Send feedback